Discontinue use if infection develops; if allergic reaction occurs; at 1st sign of tendon inflammation; in cases of Cushing's syndrome &/or adrenal suppression. Do not prematurely discontinue use. Not to be inj sub-conjunctively. Not to be introduced directly into the anterior chamber of the eye. Do not wear contact lenses after surgery for whole duration of therapy. Dry eye patients & patients whose cornea may be compromised. Prolonged use may induce antibiotic resistance w/ result of overgrowth of nonsusceptible organisms including fungi. Prolonged use (w/in 2 wk of treatment) may result in secondary ocular infections (bacterial, viral, or fungal). Examine patient w/ aid of magnification (eg, slit-lamp biomicroscopy) & fluorescein staining. Monitor patients during prolonged use. Systemic absorption may be reduced w/ nasolacrimal occlusion by compression of lacrimal ducts. Contains benzalkonium Cl. Temporarily blurred vision or other visual disturbances may affect ability to drive or use machines. Renal/hepatic impairment. Not recommended during pregnancy & especially during 1st 3 mth. No data are available to whether relevant amounts of dexamethasone are transferred into human milk. Not recommended in childn & adolescents <18 yr. Dexamethasone: Increased risk of corticosteroid-induced IOP in predisposed patients eg, diabetes. May slow corneal wound healing. Perforations in diseases causing thinning of the cornea or sclera. May promote, aggravate or mask signs & symptoms of eye infections caused by opportunistic microorganisms. Frequently check IOP. Consider referral to an ophthalmologist if patient presents w/ symptoms eg, blurred vision or other visual disturbances. Concomitant use w/ topical ocular NSAIDs may increase potential for healing problems.
Sign Out
